- Home
- CEPF vs PHR Comparison
CEPF vs PHR Comparison
Compare CEPF & PHR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CEPF | PHR |
|---|---|---|
| Founded | 2021 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Business Services |
| Sector | Finance | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 590.1M | 583.9M |
| IPO Year | N/A | 2019 |
Fundamental Metrics
Financial Performance| Metric | CEPF | PHR |
|---|---|---|
| Price | $10.30 | $8.86 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 18 |
| Target Price | N/A | ★ $21.18 |
| AVG Volume (30 Days) | 65.1K | ★ 1.2M |
| Earning Date | 01-01-0001 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 103.92 |
| EPS | N/A | ★ 0.04 |
| Revenue | N/A | ★ $480,591,000.00 |
| Revenue This Year | N/A | $8.43 |
| Revenue Next Year | N/A | $5.10 |
| P/E Ratio | ★ $96.45 | $218.88 |
| Revenue Growth | N/A | ★ 14.48 |
| 52 Week Low | $10.09 | $7.77 |
| 52 Week High | $10.67 | $32.76 |
Technical Indicators
Market Signals| Indicator | CEPF | PHR |
|---|---|---|
| Relative Strength Index (RSI) | 55.32 | 42.20 |
| Support Level | $10.22 | $8.71 |
| Resistance Level | $10.35 | $12.68 |
| Average True Range (ATR) | 0.03 | 0.45 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 60.00 | 23.51 |
Price Performance
Historical ComparisonAbout CEPF Cantor Equity Partners IV Inc. Class A Ordinary Shares
Cantor Equity Partners IV Inc is a blank check company.
About PHR Phreesia Inc.
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.